MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24

Medtronic plc

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026

$92.77−1.98 (-2.09%)

Close on Oct 19, 2026

Market cap: $119.22B
P/E (TTM): 22.8
Dividend yield: 3.06%

Medtronic plc income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-04-24	FY 2025 2025-04-25	FY 2024 2024-04-26	FY 2023 2023-04-28	FY 2022 2022-04-29	FY 2021 2021-04-30	FY 2020 2020-04-24	FY 2019 2019-04-26	FY 2018 2018-04-27	FY 2017 2017-04-28	FY 2016 2016-04-29	FY 2015 2015-04-24	FY 2014 2014-04-25	FY 2013 2013-04-26
Revenue	36,364	33,537	32,364	31,227	31,686	30,117	28,913	30,557	29,953	29,710	28,833	20,261	17,005	16,590
Cost of Revenue	12,721	11,632	11,216	10,719	10,145	10,483	9,424	9,155	9,067	9,294	9,142	6,309	4,333	4,126
Gross Profit	23,643	21,905	21,148	20,508	21,541	19,634	19,489	21,402	20,898	20,419	19,691	13,952	12,672	12,464
Research & Development	2,873	2,732	2,735	2,696	2,746	2,493	2,331	2,330	2,256	2,193	2,224	1,640	1,477	1,557
Selling, General & Admin	11,784	10,849	10,736	10,415	10,292	10,148	10,109	10,418	10,238	10,018	9,469	6,904	5,847	5,698
Operating Income	6,467	5,955	5,144	5,485	5,752	4,484	4,791	6,268	6,640	5,383	5,361	3,766	3,813	4,402
Interest Expense	715	729	719	636	553	925	1,092	1,444	1,146	1,094	1,386	666	379	388
Interest & Investment Income	–	–	–	–	–	–	–	–	397	366	431	386	271	237
Other Non-Operating Income	384	402	412	515	318	336	356	373	181	313	-107	-118	-181	-108
Merger & Restructuring Charges	370	303	389	647	335	539	462	–	–	–	–	–	–	–
Asset Impairment Charges	0	0	371	0	515	0	0	0	0	0	0	0	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	0	0	697	0	0	138	–	–
Legal Settlements	–	–	–	30	95	188	–	–	–	–	–	–	–	–
Pretax Income	6,136	5,628	4,837	5,364	5,517	3,895	4,055	5,197	5,675	4,602	4,336	3,486	3,705	4,251
Income Tax Expense	1,299	936	1,133	1,580	456	265	-751	547	2,580	578	798	811	640	784
Net Income incl. Noncontrolling Interests	4,837	4,691	3,705	3,784	5,062	3,630	4,806	4,650	3,095	4,024	3,538	2,675	–	–
Minority Interest in Earnings	37	29	28	26	22	24	17	19	-9.00	-4.00	0	0	–	–
Net Income	4,801	4,662	3,676	3,758	5,039	3,606	4,789	4,631	3,104	4,028	3,538	2,675	3,065	3,467
Net Income to Common	–	–	–	–	–	–	–	–	–	–	3,538	2,675	3,065	3,467
EPS (Basic)(per share)	3.75	3.63	2.77	2.83	3.75	2.68	3.57	3.44	2.29	2.92	2.51	2.44	3.06	3.40
EPS (Diluted)(per share)	3.73	3.61	2.76	2.82	3.73	2.66	3.54	3.41	2.27	2.89	2.48	2.41	3.02	3.37
Shares Outstanding (Basic, Weighted)(shares)	1,282	1,286	1,328	1,330	1,342	1,345	1,341	1,346	1,357	1,379	1,410	1,096	1,002	1,019
Shares Outstanding (Diluted, Weighted)(shares)	1,288	1,290	1,330	1,333	1,351	1,354	1,351	1,358	1,368	1,391	1,426	1,109	1,014	1,028
Dividend per Share(per share)	2.84	2.80	2.76	2.72	2.52	2.32	2.16	2.00	1.84	1.72	1.52	1.22	1.12	1.04
EBITDA	9,425	8,816	7,791	8,182	8,459	7,186	7,454	8,927	9,284	8,300	8,181	5,072	4,663	5,221
Net Interest Income	383	511	597	386	186	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 65.0%
Operating margin: 18.1%
Net margin: 13.9%
Return on equity, FY2026: 9.8%

Financial strength

Current ratio: 2.07
Debt to equity: 0.56
Debt to assets: 30.2%
Cash to current liabilities: 14.3%

Valuation

P/E ratio: 22.8
Price to sales: 3.18
Price to book: 2.37
Dividend yield: 3.06%